[1]
Z. Klaassen, K. Li, W. Kassouf, P. C. Black, A. Dragomir, and G. S. Kulkarni, “Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer”, CUAJ, vol. 11, no. 6, pp. 173–81, Jun. 2017.